SOTYKTU 6 mg film coated tablets
*Company:
Bristol-Myers Squibb Pharma EEIGStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 17 July 2024
File name
ie-spc-clean-sotyktu (03Jul24).pdf
Reasons for updating
- Change to section 6.3 - Shelf life
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 20 May 2024
File name
ie-spc-clean-sotyktu (23Apr24).pdf
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Change to section 5.1 - Pharmacodynamic properties - the ATC code has been updated.
Change to section 10 - Date of revision of the text
Updated on 28 February 2024
File name
ie-pil-Sotyktu (24Mar23).pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
New Patient Information Leaflet for a new medicinal product
Updated on 20 February 2024
File name
ie-spc-clean (24Mar23).pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
New SmPC for a new medicinal product SOTYKTU (deucravacitinib).
Updated on 20 February 2024
File name
ie-spc-clean (24Mar23).pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
New SmPC for a new medicinal product SOTYKTU (deucravacitinib).